1-8 of 8
Louis M. Staudt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Cyclin D1–Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma

Available to Purchase
Santiago Demajo, Robert Albero, Guillem Clot, Giancarlo Castellano, Alba Navarro, Cristina Capdevila, Anna Enjuanes, Ferran Nadeu, Eva Giné, Magda Pinyol, Elaine S. Jaffe, German Ott, Louis M. Staudt, Andreas Rosenwald, David W. Scott, Lisa M. Rimsza, Armando López-Guillermo, Sílvia Beà, Elias Campo, Pedro Jares
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (1): 213–225.
https://doi.org/10.1158/1078-0432.CCR-20-2868
Published: 04 January 2021
View articletitled, A Cyclin D1–Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma
Open the PDF for A Cyclin D1–Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Free
Myron S. Czuczman, Marek Trněný, Andrew Davies, Simon Rule, Kim M. Linton, Nina Wagner-Johnston, Randy D. Gascoyne, Graham W. Slack, Pierre Brousset, David A. Eberhard, Francisco J. Hernandez-Ilizaliturri, Gilles Salles, Thomas E. Witzig, Pier Luigi Zinzani, George W. Wright, Louis M. Staudt, Yandan Yang, P. Mickey Williams, Chih-Jian Lih, Jacqueline Russo, Anjan Thakurta, Patrick Hagner, Pierre Fustier, Dale Song, Ian D. Lewis
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (15): 4127–4137.
https://doi.org/10.1158/1078-0432.CCR-16-2818
Published: 01 August 2017
View articletitled, A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Open the PDF for A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab

Free
Javeed Iqbal, Paul N. Meyer, Lynette M. Smith, Nathalie A. Johnson, Julie M. Vose, Timothy C. Greiner, Joseph M. Connors, Louis M. Staudt, Lisa Rimsza, Elaine Jaffe, Andreas Rosenwald, German Ott, Jan Delabie, Elias Campo, Rita M. Braziel, James R. Cook, Raymond R. Tubbs, Randy D. Gascoyne, James O. Armitage, Dennis D. Weisenburger, Wing C. Chan
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (24): 7785–7795.
https://doi.org/10.1158/1078-0432.CCR-11-0267
Published: 18 December 2011
View articletitled, BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab
Open the PDF for BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab in another window
Includes: Supplementary data
Journal Articles

Accurate Classification of Diffuse Large B-Cell Lymphoma into Germinal Center and Activated B-Cell Subtypes Using a Nuclease Protection Assay on Formalin-Fixed, Paraffin-Embedded Tissues

Free
Lisa M. Rimsza, George Wright, Mark Schwartz, Wing C. Chan, Elaine S. Jaffe, Randy D. Gascoyne, Elias Campo, Andreas Rosenwald, German Ott, James R. Cook, Raymond R. Tubbs, Rita M. Braziel, Jan Delabie, Tom P. Miller, Louis M. Staudt
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (11): 3727–3732.
https://doi.org/10.1158/1078-0432.CCR-10-2573
Published: 01 June 2011
View articletitled, Accurate Classification of Diffuse Large B-Cell Lymphoma into Germinal Center and Activated B-Cell Subtypes Using a Nuclease Protection Assay on Formalin-Fixed, Paraffin-Embedded Tissues
Open the PDF for Accurate Classification of Diffuse Large B-Cell Lymphoma into Germinal Center and Activated B-Cell Subtypes Using a Nuclease Protection Assay on Formalin-Fixed, Paraffin-Embedded Tissues in another window
Journal Articles

A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

Free
William W.L. Choi, Dennis D. Weisenburger, Timothy C. Greiner, Miguel A. Piris, Alison H. Banham, Jan Delabie, Rita M. Braziel, Huimin Geng, Javeed Iqbal, Georg Lenz, Julie M. Vose, Christine P. Hans, Kai Fu, Lynette M. Smith, Min Li, Zhongfeng Liu, Randy D. Gascoyne, Andreas Rosenwald, German Ott, Lisa M. Rimsza, Elias Campo, Elaine S. Jaffe, David L. Jaye, Louis M. Staudt, Wing C. Chan
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (17): 5494–5502.
https://doi.org/10.1158/1078-0432.CCR-09-0113
Published: 31 August 2009
View articletitled, A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
Open the PDF for A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy in another window
Includes: Supplementary data
Journal Articles

IRF4: Immunity. Malignancy! Therapy?

Free
Arthur L. Shaffer, N.C. Tolga Emre, Paul B. Romesser, Louis M. Staudt
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (9): 2954–2961.
https://doi.org/10.1158/1078-0432.CCR-08-1845
Published: 30 April 2009
View articletitled, IRF4: Immunity. Malignancy! Therapy?
Open the PDF for IRF4: Immunity. Malignancy! Therapy? in another window
Journal Articles

Unique Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Human B-Cell Chronic Lymphocytic Leukemia

Free
Sivasubramanian Baskar, Ka Yin Kwong, Thomas Hofer, Jessica M. Levy, Michael G. Kennedy, Elinor Lee, Louis M. Staudt, Wyndham H. Wilson, Adrian Wiestner, Christoph Rader
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (2): 396–404.
https://doi.org/10.1158/1078-0432.CCR-07-1823
Published: 25 January 2008
View articletitled, Unique Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Human B-Cell Chronic Lymphocytic Leukemia
Open the PDF for Unique Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Human B-Cell Chronic Lymphocytic Leukemia in another window
Journal Articles

Small Molecule Inhibitors of IκB Kinase Are Selectively Toxic for Subgroups of Diffuse Large B-Cell Lymphoma Defined by Gene Expression Profiling

Free
Lloyd T. Lam, R. Eric Davis, Jackie Pierce, Michael Hepperle, Yajun Xu, Maria Hottelet, Yuhua Nong, Danyi Wen, Julian Adams, Lenny Dang, Louis M. Staudt
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 28–40.
https://doi.org/10.1158/1078-0432.28.11.1
Published: 21 January 2005
View articletitled, Small Molecule Inhibitors of IκB Kinase Are Selectively Toxic for Subgroups of Diffuse Large B-Cell Lymphoma Defined by Gene Expression Profiling
Open the PDF for Small Molecule Inhibitors of IκB Kinase Are Selectively Toxic for Subgroups of Diffuse Large B-Cell Lymphoma Defined by Gene Expression Profiling in another window